Navigation Links
fibrosis in Medical Technology

Cystic Fibrosis - Liposomal Tobramycin Receives Second Orphan Drug Designation Within Weeks

... for infections of the respiratory tract in cystic fibrosis patients has received a second orphan drug ... can cause lethal infections in cystic fibrosis patients. For Axentis Pharma AG of Zurich, ... B. cepacia infections still occur in cystic fibrosis patients and can lead to fatal sepsis. The cell ...

Transave Receives $2.2 Million Cystic Fibrosis Foundation Award for Development of ARIKACE(TM)

... JUNCTION, N.J., June 25 /PRNewswire/ -- Cystic fibrosis Foundation Therapeutics Inc., the nonprofit affiliate of the Cystic fibrosis Foundation, has provided a $2.2 million award to ... to treat Pseudomonas lung infections in cystic fibrosis (CF) and non-CF bronchiectasis patients. ...

New Legislation Seeks to Boost Participation in Clinical Trials for Rare Diseases

... populations. This is particularly true for cystic fibrosis (CF). More than 30 promising CF drugs are in ... more people with rare diseases - including cystic fibrosis - to participate in clinical trials," said Robert J. Beall, Ph.D., president and CEO of the Cystic fibrosis Foundation. ...

Results of Two Phase 3 CAPACITY Studies of Pirfenidone in IPF Presented at American Thoracic Society (ATS)

... pirfenidone in patients with idiopathic pulmonary fibrosis (IPF) were presented today in an oral ... About IPF Idiopathic pulmonary fibrosis (IPF) is a disabling and ultimately fatal disease ... portfolio addressing idiopathic pulmonary fibrosis (IPF) and hepatitis C virus (HCV) infections. ...

Paloma Pharmaceuticals Presents at the Association for Research in Vision and Ophthalmology 2009 Meeting

... and reduce the incidence of subretinal fibrosis without obvious side effects to the retina," says ... vitreoretinopathy (PVR) and subretinal fibrosis (scarring). When the retina becomes separated ... space between the retina and the RPE, subretinal fibrosis is the result and can prevent the recovery of ...

Pharmaxis Announces Positive Results of Phase 3 Cystic Fibrosis Trial

... the leading cause of death for people with cystic fibrosis and this deterioration now averages 1-2% per ... formulation to publish positive results in cystic fibrosis it promises convenience for patients who have ... authorisation for Bronchitol for treating cystic fibrosis in Europe and elsewhere. Pharmaxis will now move ...

Cystic Fibrosis - Orphan Drug Designation for Innovative Treatment Against Lung Infections by Axentis Pharma AG

... for infections of the respiratory tract in cystic fibrosis patients has received orphan drug designation in ... of the respiratory tract in patients with cystic fibrosis that is delivered directly to the site of ... a clinical stage treatment against cystic fibrosis (CF). About Fluidosome technology ...

Pharmaxis Announces Milestone in Phase III Trial for Cystic Fibrosis

... for Bronchitol for treating cystic fibrosis in Europe and elsewhere. The results of ... landscape for people living with cystic fibrosis and provide a new therapeutic regimen that helps ... pharmaceutical markets are affected with cystic fibrosis and no products have been approved to improve ...

FDA Approves an Expanded Indication for Peginterferon-Based Combination Therapy for Patients With Chronic Hepatitis C

... interferon treatment, significant bridging fibrosis or cirrhosis, or HCV genotype 1 infection. It is ... interferon treatment, significant bridging fibrosis or cirrhosis, or HCV genotype 1 infection. ... 2,293 adult patients with moderate-to-severe fibrosis or cirrhosis who failed previous treatment with ...

Positive Data From Lung Study May Lead to First FDA Approved Treatment for Pulmonary Fibrosis

... -- The Coalition for Pulmonary fibrosis (CPF) is calling this a historic time in the ... be saved," Shreve said. About Pulmonary fibrosis (PF) Pulmonary fibrosis (PF) is a lung disorder characterized by a ...

PTC Therapeutics Completes Enrollment of Pivotal Trial in Muscular Dystrophy

... in patients with nonsense mutation cystic fibrosis (nmCF) in 2009. The United States Adopted ... drug status for the treatment of DMD and cystic fibrosis due to nonsense mutations. The FDA has also ... Center for Research Resources and the Cystic fibrosis Foundation Therapeutics Inc. (the nonprofit ...

Long-term Follow Up Interim Data Show Nplate(TM) Increased and Sustained Platelet Counts in Adult Chronic ITP Patients

... with no evidence of progression to collagen fibrosis or chronic idiopathic myelofibrosis. ... Reticulin Formation and Risk for Bone Marrow fibrosis -- Nplate administration increases the ... to 10 mcg/kg. -- Progression to marrow fibrosis with cytopenias was not reported in ...

PTC Announces Data Showing That PTC124 Causes Statistically Significant Improvements in Chloride Channel Function in Cystic Fibrosis Patients

... chloride channel function of children with cystic fibrosis (CF) caused by a particular genetic mutation, ... head of the department of pediatrics and Cystic fibrosis Center at Hadassah University Hospital. (Logo: ... Vice President of Medical Affairs at the Cystic fibrosis Foundation, on promising developments in CF ...

Mpex Pharmaceuticals Presents New Data on MP-376 in Cystic Fibrosis

... eFlow Nebulizer System for use in cystic fibrosis (CF) and chronic obstructive pulmonary disease ... are being presented at the North American Cystic fibrosis Conference (NACFC) and ICAAC/IDSA meetings taking ... bacterial exacerbations in patients with cystic fibrosis and COPD. The company has also built a discovery ...

PTC Therapeutics Announces Data Showing Six-Minute Walk Test Consistently Measures Ambulatory Function in Patients With Duchenne Muscular Dystrophy

... European Commission for the treatment of cystic fibrosis and DMD due to nonsense mutations. The FDA has ... for Research Resources and notably, the Cystic fibrosis Foundation Therapeutics Inc. (the nonprofit affiliate of the Cystic fibrosis Foundation), which recently expanded support of ...

Cystic Fibrosis Axentis Pharma Initiates Clinical Trial for Lung Infections

... treatment of severe pulmonary infection in cystic fibrosis patients. The new formulation allows ... the treatment of pulmonary infection in cystic fibrosis patients. The product ARB-CF0223 ­ also known as ... to the endobronchial sites of infection in cystic fibrosis patients. This results in prolonged, high local ...

Second Pivotal Phase 3 Trial In Cystic Fibrosis Begins

... 3 clinical trial evaluating Bronchitol in cystic fibrosis sufferers. The Phase 3 trial is being conducted ... seeks approval to market Bronchitol for cystic fibrosis in the United States. Pharmaxis Chief Executive ... the FDA and with assistance from the U.S. Cystic fibrosis Foundation. This trial follows the recent closure ...

Bronchitol Phase 3 Cystic Fibrosis Trial Completes Recruitment

... trial of Bronchitol for the treatment of cystic fibrosis has completed enrolment. The first efficacy ... forward to the results helping to shape cystic fibrosis clinical practice in the future." Pharmaxis has ... pharmaceutical markets are affected with cystic fibrosis and no products have been approved to ...

Bronchitol Cystic Fibrosis Dose Trial Results Positive

... in Lung Function of Cystic fibrosis Patients SYDNEY, Australia, Aug. 11 ... 40 mg of Bronchitol in 48 patients with cystic fibrosis at 12 centres across Canada and Argentina. ... flow) and the respiratory domain of the cystic fibrosis quality of life questionnaire (CFQR). ...

PTC Therapeutics Announces $25 Million Award From Cystic Fibrosis Foundation Therapeutics for Development of PTC124

... Therapy to Address an Underlying Cause of Cystic fibrosis - SOUTH PLAINFIELD, N.J. and BETHESDA, Md., ... -- PTC Therapeutics, Inc. (PTC) and Cystic fibrosis Foundation Therapeutics, Inc. (CFFT), the nonprofit affiliate of the Cystic fibrosis Foundation, today announced the expansion of an ...

The Ocean Becomes a Pipeline To A Cure for Cystic Fibrosis

... and quality of life for people with cystic fibrosis (CF), a fatal genetic disease that causes the ... in Australia noticed young surfers with cystic fibrosis had significantly healthier lungs. The doctors ... led the Southern California Chapter of the Cystic fibrosis Foundation to form a "PIPELINE TO A CURE" ...

Transave Announces Positive Phase II Results for Once-Daily Arikace(TM) in the Treatment of Cystic Fibrosis Patients Who Have Pseudomonas Lung Infections

... Data Presented at the European Cystic fibrosis Society Conference MONMOUTH JUNCTION, N.J., ... is being developed for the treatment of cystic fibrosis (CF) patients who have lung infections due to the ... presented today at the 31st European Cystic fibrosis Society (ECFS) Conference in Prague, Czech ...

PTC Therapeutics Announces Data from Additional Clinical Studies of PTC124 in Cystic Fibrosis Confirming Activity

... - Data Presented at the 31st European Cystic fibrosis Conference - SOUTH PLAINFIELD, N.J. and PRAGUE, ... new data from two studies of PTC124 in cystic fibrosis (CF). Results from an Israeli Phase 2a extension ... CF." About Cystic Fibrosis Cystic fibrosis (CF) is among the most common life-threatening ...

PTC Therapeutics Announces Data Supporting Cough Frequency as a New Outcome Measure in Evaluating Treatments for Cystic Fibrosis

... - Findings Show Cystic fibrosis Patients Cough More Than 600 Times Per Day ... head of the Department of Pediatrics and Cystic fibrosis Center, Hadassah University Hospital. "Chronic ... and children. Patients with CF lack the cystic fibrosis transmembrane conductance regulator ...

PTC Therapeutics Announces Initiation of Phase 2b Registration-Directed Clinical Trial of PTC124 in Duchenne/Becker Muscular Dystrophy

... we have achieved to date in DMD and cystic fibrosis (CF) and constitutes a major step forward ... muscular dystrophy (DMD) and cystic fibrosis (CF). It is estimated that 13% of the cases of ... the Muscular Dystrophy Association (MDA), Cystic fibrosis Foundation Therapeutics, Inc. (CFFT), Parent ...

InterMune Announces Progress on Pirfenidone in IPF

... pirfenidone in patients with idiopathic pulmonary fibrosis (IPF). The roll-over study will be open to ... Pirfenidone in Patients with Idiopathic Pulmonary fibrosis in Japan" [Session C95], is now posted at ... . About IPF Idiopathic pulmonary fibrosis (IPF) is a disabling and ultimately fatal disease ...

Cystic Fibrosis Foundation Announces Positive Early Results for Phase 2 Clinical Trial of VX-770 - an Oral Compound to Treat CF

... Md., March 27 /PRNewswire/ -- The Cystic fibrosis Foundation announced today that VX-770, an oral ... philanthropy was wholly untested, the Cystic fibrosis Foundation was willing to take a chance that ... safety and efficacy of the compound. Cystic fibrosis is a life-threatening genetic disease that ...

PTC Therapeutics Announces Publication of Preclinical Data in PNAS

... and Restores Protein Function in Cystic fibrosis Model SOUTH PLAINFIELD, N.J., Feb. 4 ... active in a preclinical model of cystic fibrosis (CF). These results support and add to research ... cases of most inherited diseases, such as cystic fibrosis (10%) and Hurler's syndrome (70%). "The ...

Cystic Fibrosis Foundation Reports Upward Trend for Key Health Outcomes

... key indicators of health for people with cystic fibrosis -- including lung function and nutritional status ... the country, we are seeing great care for cystic fibrosis get even better," said Bruce C. Marshall, M.D., ... purposes. About the Cystic fibrosis Foundation The ...

Pediatric Pulmonary Expert Comments on Study of Lung Transplants for Cystic Fibrosis

... of Utah research team, which found that cystic fibrosis (CF) patients younger than age 18 did not survive ... than ever in referring children with cystic fibrosis for lung transplantation, with careful ... child's illness," said Allen. He said that cystic fibrosis centers must provide appropriate social and ...

Schering-Plough Highlights PEGINTRON(TM) Clinical Data Presentations at the American Association for the Study of Liver Diseases (AASLD) 2007 Annual Meeting

... in chronic hepatitis C nonresponder patients with fibrosis or cirrhosis. The goal of maintenance therapy in ... Alfa-2b Leads to a Significant Reduction in fibrosis and Inflammatory Score in Chronic Hepatitis C Nonresponder Patients with fibrosis or Cirrhosis; S. Kaiser, et al., Abstract 1311, ...

PTC Therapeutics Announces Additional Results from Phase 2 Study of PTC124 in Duchenne Muscular Dystrophy

... Society meeting and North American Cystic fibrosis Conference, further support our belief that ... of longer-term studies in DMD and cystic fibrosis (CF) as well as additional proof of concept ... of PTC124 in nonsense-mutation-mediated cystic fibrosis (CF) and Duchenne muscular dystrophy (DMD). It ...

Man's Best Friend May Open Door to Understanding Fibrotic Lung Disease in Human and Animal Populations

... to Discuss Joint Research Efforts Into Pulmonary fibrosis and Other Fibrotic Lung Diseases LAFAYETTE, ... that the opportunity to study canine pulmonary fibrosis may provide a new approach that will lead to the ... About the Coalition for Pulmonary fibrosis The Coalition for ...

Promising Cystic Fibrosis Compound on Track for Development

... Made Possible by Early Investment by Cystic fibrosis Foundation ... . About the Cystic fibrosis Foundation The Cystic fibrosis Foundation is the leading organization devoted ...

TriLink BioTechnologies, Inc. Announces Supply Agreement With Osmetech Molecular Diagnostics

... to supply reagents for Osmetech's recently launched eSensor(R) Cystic fibrosis Carrier Detection (CFCD) System and the eSensor(R) XT-8 System for ... platform and the eSensor(R) XT-8 platform, presently available for Cystic fibrosis Carrier Detection and Warfarin Sensitivity testing, respectively. The ...

InterMune to Announce Results of Phase 3 CAPACITY Program of Pirfenidone in IPF Tomorrow, February 3

... from its Phase 3 CAPACITY program of pirfenidone in idiopathic pulmonary fibrosis (IPF) prior to market open on Tuesday, February 3. InterMune will conduct ... has a research and development portfolio addressing idiopathic pulmonary fibrosis (IPF) and hepatitis C virus (HCV) infections. The pulmonology portfolio ...

Nanoemulsion Kills Highly Resistant Bacteria Found in Patients With Cystic Fibrosis

... also demonstrated bactericidal activity in the presence of cystic fibrosis sputum and against bacterial biofilms, protective coatings that surround ... The company expects to initiate a phase 1 study in humans with cystic fibrosis in 2010. About NanoBio NanoBio(R) Corp. is a privately held ...

Bioheart Reports Promising Results From Preclinical Study of Adipose-Derived Acute Cell Therapy

... angiogenesis (new blood vessel formation) when evaluated at 10 days, early fibrosis (fibrous connective tissue formation) when evaluated at 30 days and, in some cases, established fibrosis when evaluated at 60 days. The treatment arms, however, showed a tendency ...

Mpex Initiates a Phase 2 Clinical Trial of Aerosol MP-376 in the Treatment of Chronic Bacterial Infections in Cystic Fibrosis Patients

... 3 studies, which we hope to initiate in 2009." Patients with cystic fibrosis (CF) suffer from chronic infections of the lower respiratory tract that ... for the prevention of bacterial exacerbations in patients with cystic fibrosis and severe chronic bronchitis. The company has also built a discovery and ...

Inspire's Phase 3 CF Trial, Using PARI's Nebulizer & Compressor, Shows Positive Top-Line Results

... LC STAR nebulizer and PRONEB Ultra compressor for the treatment of cystic fibrosis (CF). "We are pleased to see these positive top-line results and hope ... and minimal medication waste. Denufosol for the treatment of cystic fibrosis has been granted Fast Track designation and orphan drug status in the ...
Other Contents
(Date:8/28/2014)... of complex systems. Their infrastructure equipment requires ancillary ... transport to supply fuel, and ICT systems for ... chain is interconnected with a wider network and ... UK-based scientists has studied various aspects of inter-network ... published in EPJ B by Gaihua Fu from ...
(Date:8/28/2014)... the most commonly diagnosed learning disability in the ... occurs when the regions of the brain that ... use of non-invasive functional neuroimaging tools has helped ... However, most prior work has focused on only ... gap in our understanding of how multiple brain ...
(Date:8/28/2014)... German . ... the help of sophisticated assembly lines. Mobile assembly carriers, on ... of these assembly lines. In the case of a car ... arranged in a precise spatial and chronological sequence, resulting in ... The creation of such an assembly line at molecular level ...
Breaking Biology News(10 mins):Inter-dependent networks stress test 2Dyslexic readers have disrupted network connections in the brain 2Nanoscale assembly line 2Nanoscale assembly line 3
(Date:8/30/2014)... According to the latest review on DailyGossip.org, this is ... skin health. It seems that the method is so popular ... 138,000 patients from all over the world. , The ... method will not only eliminate acne forever, but will also ... this program unique among other methods of curing candida is ...
(Date:8/30/2014)... 31, 2014 As the economy continues ... especially spa style bathrooms and in-home fitness centers, the ... an increase in interest not only in designing and ... and health benefits of sauna. Through working with ... North American Sauna Society provides a strong knowledge base ...
(Date:8/30/2014)... (PRWEB) August 31, 2014 Atlanta based ... dealerships to help raise money and awareness for ALS ... , General Managers, staff, and even Vice President Jimmy ... on film and can be viewed on their Youtube ... in the challenge, general managers and staff also took ...
(Date:8/30/2014)... Recently, iFitDress.com, one of the most loved online ... classy bridesmaid dresses . For additional information, the firm ... to 62 percent off) for all people who place ... True enough, iFitDress.com is an industry leader when it ... persists in making trendy products that can flatter various ...
(Date:8/30/2014)... According to Bloomberg , U.S. District ... Pharmaceutical Co. and Eli Lilly & Co. to pay ... drugmakers concealed information about a risk of bladder cancer ... v. Takeda Pharmaceuticals North America Inc. (12-cv-00064), was filed ... (Lafayette).* , According to Bloomberg, Takeda and Lilly disagree ...
Breaking Medicine News(10 mins):Health News:Acne No More Review Reveals Unusual Tip to Eliminate Acne Permanently 2Health News:As Interest in Saunas Increases, the North American Sauna Society Increases Outreach to Provide Education on History, Design, and Culture 2Health News:Jim Ellis Automotive Group Take the ALS Ice Bucket Challenge 2Health News:Classy Bridesmaid Dresses Announced By Loved Online Supplier iFitDress.com 2Health News:The Law Office of Melinda J. Helbock A.P.C. Comments on Decision to Uphold $9 Billion Actos Award 2
Other TagsOther Tags